Scientists test cancer Drug's impact on common medicine
NCT ID NCT07241065
Summary
This study aims to understand how a cancer drug called capivasertib affects the way the body processes a common cough medicine, dextromethorphan. It will involve 35 healthy volunteers who will take both drugs in a specific order. The main goal is to measure drug levels in the blood to see if taking them together changes how the body handles them, which is important for future patient safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.